Differential effects of the CCK antagonist, MK-329, on analgesia induced by morphine, social conflict (opioid) and defeat experience (non-opioid) in male mice
- 1 October 1989
- journal article
- research article
- Published by Elsevier in Neuropharmacology
- Vol. 28 (10) , 1025-1032
- https://doi.org/10.1016/0028-3908(89)90113-5
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Morphine-induced analgesia in the rat paw pressure test is blocked by CCK and enhanced by the CCK antagonist MK-329Neuropharmacology, 1989
- The novel CCK antagonist L364,718 abolishes caerulein-but potentiates morphine-induced antinociceptionEuropean Journal of Pharmacology, 1988
- Enhancement of morphine analgesia and prevention of morphine tolerance in the rat by the cholecystokinin antagonist L-364,718European Journal of Pharmacology, 1988
- Male scent-induced analgesia in the deer mouse, Peromyscus maniculatus: Involvement of benzodiazepine systemsPhysiology & Behavior, 1988
- Autoradiographic localization and biochemical characterization of peripheral type CCK receptors in rat CNS using highly selective nonpeptide CCK antagonistsJournal of Neuroscience, 1987
- Antinociceptive profile of sulfated CCK-8Neuropharmacology, 1986
- Opiate Antagonistic Function of Cholecystokinin in Analgesia and Energy Balance SystemsaAnnals of the New York Academy of Sciences, 1985
- Evidence for the Neuropeptide Cholecystokinin as an Antagonist of Opiate AnalgesiaScience, 1983
- Opioid-Like Analgesia in Defeated MiceScience, 1982
- Antinociceptive effect of centrally administered caerulein and cholecystokinin octapeptide (CCK-8)European Journal of Pharmacology, 1981